EP0988295A4 - Piperidines a substitution heterocyclique et utilisations de ces dernieres - Google Patents
Piperidines a substitution heterocyclique et utilisations de ces dernieresInfo
- Publication number
- EP0988295A4 EP0988295A4 EP98931350A EP98931350A EP0988295A4 EP 0988295 A4 EP0988295 A4 EP 0988295A4 EP 98931350 A EP98931350 A EP 98931350A EP 98931350 A EP98931350 A EP 98931350A EP 0988295 A4 EP0988295 A4 EP 0988295A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- heterocyclic substituted
- substituted piperidines
- piperidines
- heterocyclic
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87784697A | 1997-06-18 | 1997-06-18 | |
US877846 | 1997-06-18 | ||
PCT/US1998/012668 WO1998057940A1 (fr) | 1997-06-18 | 1998-06-17 | Piperidines a substitution heterocyclique et utilisations de ces dernieres |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0988295A1 EP0988295A1 (fr) | 2000-03-29 |
EP0988295A4 true EP0988295A4 (fr) | 2003-08-13 |
Family
ID=25370847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98931350A Withdrawn EP0988295A4 (fr) | 1997-06-18 | 1998-06-17 | Piperidines a substitution heterocyclique et utilisations de ces dernieres |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0988295A4 (fr) |
JP (1) | JP2002505683A (fr) |
AU (1) | AU740064B2 (fr) |
CA (1) | CA2294549A1 (fr) |
WO (1) | WO1998057940A1 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228870B1 (en) | 1998-11-10 | 2001-05-08 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1a adrenoceptor antagonists |
US6319932B1 (en) | 1998-11-10 | 2001-11-20 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1A adrenoceptor antagonists |
US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
GB2344821A (en) | 1998-12-17 | 2000-06-21 | Merck & Co Inc | Crystalline pharmaceutically acceptable salt of an oxazolidinone derivative |
US6372911B1 (en) * | 1999-02-09 | 2002-04-16 | Merck & Co., Inc. | Process for preparing β-hydroxycarbamates and their conversion to oxazolidinones |
US6645968B2 (en) | 1999-08-03 | 2003-11-11 | Abbott Laboratories | Potassium channel openers |
GB2355456A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355263A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355457A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists |
US8835426B2 (en) | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
EP2229368A1 (fr) | 2007-12-11 | 2010-09-22 | Vitae Pharmaceuticals, Inc. | Inhibiteurs cycliques d'urée de la 11béta-hydroxystéroïde déhydrogénase 1 |
CA2729998A1 (fr) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibiteurs de la 11 beta-hydroxysteroide deshydrogenase 1 |
CA2730499A1 (fr) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibiteurs cycliques de la 11 beta-hydroxysteroide deshydrogenase 1 |
US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
WO2011011123A1 (fr) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 basée sur la structure 1,3-oxazinan-2-one |
US8883778B2 (en) | 2009-07-01 | 2014-11-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用 |
EP2585444B1 (fr) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones comme inhibiteurs de 11-beta -hsd1 pour le traitement de troubles métaboliques |
EP2635268A1 (fr) | 2010-11-02 | 2013-09-11 | Boehringer Ingelheim International GmbH | Combinaisons pharmaceutiques destinées au traitement de troubles du métabolisme |
WO2014059265A1 (fr) * | 2012-10-11 | 2014-04-17 | Southern Research Institute | Dérivés urée et amide d'aminoalkylpipérazines et leur utilisation |
CA3120514A1 (fr) * | 2018-11-20 | 2020-05-28 | Sironax Ltd | Urees cycliques |
CN116003380B (zh) * | 2023-01-31 | 2024-07-05 | 天津大学 | 指纹识别探针、显影剂和介质表面潜指纹荧光成像方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014846A1 (fr) * | 1994-11-16 | 1996-05-23 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines et leurs utilisations |
WO1997017969A1 (fr) * | 1995-11-16 | 1997-05-22 | Synaptic Pharmaceutical Corporation | Dihydropirimidines et leurs emplois |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3334098A (en) * | 1964-05-07 | 1967-08-01 | American Cyanamid Co | 1-monocarbocyclic aryl-3-amino-alkanoyl-2-imidazolidinones |
CH611898A5 (fr) * | 1975-06-06 | 1979-06-29 | Hoffmann La Roche | |
US4377578A (en) * | 1976-12-21 | 1983-03-22 | Janssen Pharmaceutica, N.V. | Piperazine derivatives |
US4410540A (en) * | 1981-11-04 | 1983-10-18 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic 4-aroylimidazolidin-2-ones |
JPH0713017B2 (ja) * | 1986-06-18 | 1995-02-15 | 日本ケミファ株式会社 | 脳細胞保護作用を有する医薬組成物 |
JPH0755937B2 (ja) * | 1986-07-29 | 1995-06-14 | 日本曹達株式会社 | オキサ(チア)ゾリジン誘導体その製造方法及び殺ダニ剤 |
US5202345A (en) * | 1987-08-19 | 1993-04-13 | Shionogi & Co., Ltd. | Carbamoylpyrrolidone derivatives and drugs for senile dementia |
FR2698359B1 (fr) * | 1992-11-25 | 1995-10-27 | Rhone Poulenc Agrochimie | Derives de 2-alkoxy 2-imidazoline-5-ones fongicides. |
WO1995007904A1 (fr) * | 1993-09-15 | 1995-03-23 | Merck Sharp & Dohme Limited | Derives d'imidazolone et d'oxazolone utilises comme antagonistes de la dopamine |
-
1998
- 1998-06-17 JP JP50477899A patent/JP2002505683A/ja active Pending
- 1998-06-17 WO PCT/US1998/012668 patent/WO1998057940A1/fr not_active Application Discontinuation
- 1998-06-17 CA CA002294549A patent/CA2294549A1/fr not_active Abandoned
- 1998-06-17 EP EP98931350A patent/EP0988295A4/fr not_active Withdrawn
- 1998-06-17 AU AU81498/98A patent/AU740064B2/en not_active Ceased
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014846A1 (fr) * | 1994-11-16 | 1996-05-23 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines et leurs utilisations |
WO1997017969A1 (fr) * | 1995-11-16 | 1997-05-22 | Synaptic Pharmaceutical Corporation | Dihydropirimidines et leurs emplois |
Non-Patent Citations (1)
Title |
---|
See also references of WO9857940A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU8149898A (en) | 1999-01-04 |
AU740064B2 (en) | 2001-10-25 |
JP2002505683A (ja) | 2002-02-19 |
WO1998057940A1 (fr) | 1998-12-23 |
CA2294549A1 (fr) | 1998-12-23 |
EP0988295A1 (fr) | 2000-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0988295A4 (fr) | Piperidines a substitution heterocyclique et utilisations de ces dernieres | |
GB9715892D0 (en) | Heterocyclic compounds | |
ZA9811345B (en) | Piperidine derivatives | |
IL121299A0 (en) | 4-hydroxy-piperidine derivatives and their uses | |
ZA988749B (en) | New pieperazine and piperidine compounds | |
PL342400A1 (en) | Fungicidal mixtures based on amidic compounds and derivatives of piperidine | |
PL329351A1 (en) | Piperidines and pyrolydines | |
GB9704349D0 (en) | Levobupivacaine and its use | |
ZA9811346B (en) | Substituted heterocyclic benzocycloalkenes and their use as an analgesic | |
SG74120A1 (en) | Pyrrolidine and piperidine derivatives | |
EP1032559A4 (fr) | Derives d'amino-alkylphenols et composes associes | |
GB9704370D0 (en) | Levobupivacaine and its use | |
EP0998578A4 (fr) | Sel-10 et utilisations de sel-10 | |
ZA988492B (en) | Substituted tetrahydro-naphthalenes and analogous compounds | |
PL341293A1 (en) | Beta-lypothropin and application thereof | |
EP1011665A4 (fr) | Agents heterocycliques | |
GB9722023D0 (en) | Levobupivacaine and its use | |
AU9646998A (en) | Heterocyclic compounds and use thereof | |
IL134499A0 (en) | Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives | |
IL135195A0 (en) | Substituted piperidine derivatives | |
GB9706304D0 (en) | Heterocyclic agents | |
GB9722022D0 (en) | Levobupivacaine and its use | |
GB9724506D0 (en) | Levobupivacaine and its use | |
GB9704369D0 (en) | Levobupivacaine and its use | |
GB9710080D0 (en) | Levobupivacaine and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07D 417/14 B Ipc: 7C 07D 413/14 B Ipc: 7C 07D 401/14 B Ipc: 7C 07D 401/12 B Ipc: 7C 07D 265/10 B Ipc: 7C 07D 263/26 B Ipc: 7A 61K 31/495 B Ipc: 7A 61K 31/445 B Ipc: 7A 61K 31/425 B Ipc: 7A 61K 31/42 B Ipc: 7A 61K 31/415 B Ipc: 7C 07D 413/12 B Ipc: 7C 07D 411/12 B Ipc: 7C 07D 403/06 B Ipc: 7C 07D 277/14 B Ipc: 7C 07D 263/20 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030626 |
|
17P | Request for examination filed |
Effective date: 20000108 |
|
17Q | First examination report despatched |
Effective date: 20040423 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040904 |